In support of the latter concept, familial AD (FAD) mutations in PSEN1 and PSEN2, and most FAD-linked mutations in APP genes consistently alter either the levels or profile Aβ peptides that are produced [13]. This evidence concerns the gene APP and familial Alzheimer disease.